# reload+after+2024-01-20 18:26:38.697822
address1§1055 Westlakes Drive
address2§Suite 300
city§Berwyn
state§PA
zip§19312
country§United States
phone§610 727 3913
website§https://www.annovisbio.com
industry§Biotechnology
industryKey§biotechnology
industryDisp§Biotechnology
sector§Healthcare
sectorKey§healthcare
sectorDisp§Healthcare
longBusinessSummary§Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which is in Phase 3 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.
fullTimeEmployees§5
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Maria L. Maccecchini Ph.D.', 'age': 72, 'title': 'Founder, CEO, President & Executive Director', 'yearBorn': 1951, 'fiscalYear': 2022, 'totalPay': 965600, 'exercisedValue': 0, 'unexercisedValue': 3749000}, {'maxAge': 1, 'name': 'Mr. Henry  Hagopian III, M.B.A.', 'age': 55, 'title': 'Chief Financial Officer', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 510049, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Cheng  Fang Ph.D.', 'title': 'Senior Vice President of Research & Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Eve M. Damiano M.S., RAC', 'title': 'Senior Vice President of Regulatory Operations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Melissa  Gaines', 'title': 'Senior Vice President of Clinical Operations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.668
currency§USD
dateShortInterest§1702598400
forwardEps§-2.81
exchange§NYQ
quoteType§EQUITY
shortName§Annovis Bio, Inc.
longName§Annovis Bio, Inc.
firstTradeDateEpochUtc§1580308200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§e153bc75-9830-375d-bf5e-330db4df878a
messageBoardId§finmb_622711087
gmtOffSetMilliseconds§-18000000
targetHighPrice§72.0
targetLowPrice§26.0
targetMeanPrice§39.8
targetMedianPrice§35.0
recommendationMean§1.8
recommendationKey§buy
numberOfAnalystOpinions§5
quickRatio§1.783
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
